|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2400 USD | -7.69% |
|
-17.24% | -55.56% |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 05-15 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Guided Therapeutics, Inc.
Delayed Quote OTC Markets
| 22/06/2026 | 23/06/2026 | 25/06/2026 | 26/06/2026 | |
|---|---|---|---|---|
| Last | US$0.2650 | US$0.2600 | US$0.2600 | US$0.2400 |
| Volume | 250 | 14,600 | 101 | 106 |
| Change | - | -1.89% | 0.00% | -7.69% |
| Opening | US$0.2650 | US$0.2600 | US$0.2600 | US$0.2400 |
| High | US$0.2650 | US$0.2600 | US$0.2600 | US$0.2400 |
| Low | US$0.2650 | US$0.2200 | US$0.2600 | US$0.2400 |
Performance
| 1 day | -7.69% | ||
| 1 week | -17.24% | ||
| Current month | +4.80% | ||
| 1 month | +4.80% | ||
| 3 months | +20.30% | ||
| 6 months | -33.33% | ||
| Current year | -55.56% | ||
| 1 year | -14.29% | ||
| 3 years | -5.88% | ||
| 5 years | -64.18% | ||
| 10 years | -99.99% |
Volumes
marketsDaily volume
106
Estimated daily volume
106
Avg. Volume 20 sessions
8,186
Daily volume ratio
0.01
Avg. Volume 20 sessions USD
1,964.64
Record volume 1
651,663
Record volume 2
513,070
Record volume 3
477,539
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
23,168,963
Net sales ()
767,000
Number of employees
3
Sales / Employee (USD)
255,667
Free-Float
63.48 %
Free-Float capitalization (USD)
14,708,282
Average Daily Capital Traded
0.01%
Indicators
Moving average 5 days
0.2563
Moving average 20 days
0.1874
Moving average 50 days
0.1885
Moving average 100 days
0.2603
Price spread / (MMA5)
+6.79%
Price spread / (MMA20)
-21.92%
Price spread / (MMA50)
-21.46%
Price spread / (MMA100)
+8.46%
STIM
RSI 9 days
53.72
RSI 14 days
52.65
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.69% | -17.24% | -14.29% | -5.88% | 23.17M | |
| +1.44% | +10.42% | +25.66% | +0.56% | 191B | |
| +1.25% | -0.51% | -24.17% | +21.54% | 143B | |
| +1.75% | +10.74% | -1.31% | -16.43% | 139B | |
| +0.07% | -2.34% | -58.48% | -17.25% | 65.74B | |
| +1.18% | +3.91% | +16.07% | +0.38% | 52.27B | |
| -0.52% | -0.03% | -27.04% | -32.66% | 43.55B | |
| +0.37% | +7.04% | +14.13% | +16.88% | 38.41B | |
| -0.66% | +5.34% | +6.24% | +45.44% | 36.76B | |
| +1.26% | +6.77% | -11.59% | -14.81% | 29.91B | |
| Average | -0.16% | +2.41% | -7.48% | -0.22% | 73.95B | |
| Weighted average by Cap. | +1.04% | +5.58% | -3.40% | +0.34% |
Historical Quotes: Guided Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
26aaf008b40c416.bu3wxLYKSQD0D0WgFEiiaIJJk38TpzAQ-CYavATVyxo.B7Wzk45Ge1GRRRaTWHrAJuo8-Shi5QZojUVp2kGWnkgnqp-I_m5xbaREIg
| Date | Price | Volume | Total |
|---|
Course Extremes
| 1 week | 0.22 |  | 0.26 |
| 1 month | 0.18 | | 0.34 |
| Current year | 0.17 | | 0.54 |
| 1 year | 0.12 | | 0.54 |
| 3 years | 0.06 | | 0.54 |
| 5 years | 0.06 | | 0.78 |
| 10 years | 0.02 | | 6,272 |
Monthly variations
Annual variations
| 2026 | -55.56% | ||
| 2025 | +260.00% | ||
| 2024 | -2.28% | ||
| 2023 | -48.83% | ||
| 2022 | -48.29% | ||
| 2021 | +93.46% | ||
| 2020 | +125.49% | ||
| 2019 | -44.58% | ||
| 2018 | -98.80% | ||
| 2017 | -95.36% | ||
| 2016 | -99.96% | ||
| 2015 | -93.48% | ||
| 2014 | -52.10% | ||
| 2013 | -29.41% | ||
| 2012 | -55.26% | ||
| 2011 | +90.00% | ||
| 2010 | -28.57% | ||
| 2009 | +460.00% | ||
| 2008 | +5.26% | ||
| 2007 | -36.67% | ||
| 2006 | +20.00% | ||
| 2005 | -50.98% | ||
| 2004 | -74.50% | ||
| 2003 | +24.22% | ||
| 2002 | -76.67% | ||
| 2001 | -6.44% | ||
| 2000 | -38.22% | ||
| 1999 | +97.93% | ||
| 1998 | -10.65% | ||
| 1997 | -3.57% |
- Stock Market
- Stocks
- GTHP Stock
- Quotes Guided Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
